BenzingaDoubao · 实盘不做把握 6/10不做原因:已被定价
北京时间·🕒 发布 01:35:36·⟳ 抓取 01:37:27 +1m51s·⚡ 决策 10-16 01:38:55 +1m28s·11.7 天前
贝莱德Q3营收EPS双超预期后分析师上调目标价，但股价已在盘中上涨3.3%
核心催化（Q3财报）在10月14日已首发，本条Benzinga是次日盘中分析师目标价调整的汇总稿；BLK为超大市值股，3.3%涨幅与大量正面预期已在盘中被定价，目标价上调为滞后确认而非新增信息，无短线正edge。
📄 原文Benzinga↗ 原文
These Analysts Boost Their Forecasts On BlackRock After Better-Than-Expected Q3 Results
BlackRock Inc. (NYSE:BLK) on Wednesday reported better-than-expected third-quarter results. Revenue increased 19% year…
不做 BlackRock Inc.（BLK.US）
财报周三已发布，本文为次日分析师目标价上调的二手汇总稿，属滞后确认；BLK约1.7万亿超大市值，盘中已涨3.3%完成重定价，事件驱动短线无正edge，不追高
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
贝莱德Q3营收+19%、EPS大幅超预期确属利好，但财报周三已发布、股价盘中已涨3.3%反映，分析师目标价上调只是滞后跟随，对1.7万亿美元市值的BLK缺乏新增短线催化，不追高。
🔎 新鲜度:最早出现 2026-10-14 · 扩散 high · price-in 风险 high ↗
关键理由
- 业绩beat幅度可观（营收超预期3%、EPS超预期12.7%），基本面正面，适合中线持有者而非事件驱动短线
主要风险
- 业绩利好已被盘中3.3%涨幅消化，分析师目标价上调为滞后确认，追高易遇sell-the-news；超预期的可持续性（市场与AUM驱动）待后续验证
反向证据
- 做多前查反向 · 来源 web · 日期 2026-10-15 · 影响 weakens
巴克莱实际微降目标价（1420→1410），且股价盘中已涨3.3%，利好已被定价，无未消化增量
检索:BlackRock Q3 2026 earnings beat price already risen analyst target cuts 原文 ↗
先例如何影响了这次决策
对本次决策的影响:未做先例检索：本条本质是已定价财报的二手分析师汇总，不构成新的可交易催化，先例不会改变AVOID结论
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 11 ms
{"result": "search_processed_events:agent query=`blackrock blk third quarter results analyst price target raised | blackrock q3 2026 earnings beat revenue eps | 贝莱德 三季报 业绩 目标价`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"}
原文全文
展开原文 · 1,643 字
BlackRock Inc. (NYSE:BLK) on Wednesday reported better-than-expected third-quarter results.
Revenue increased 19% year over year (Y/Y) to $7.75 billion, topping the analyst consensus estimate of $7.52 billion. Adjusted earnings came in at $15.93 per share, ahead of the consensus estimate of $14.13.
Investment advisory, administration fees and securities lending revenue rose to $6.04 billion from $5.05 billion a year earlier. Securities lending revenue increased to $253 million from $203 million, led by higher spreads and increased average balances of securities on loan.
BlackRock shares rose 3.3% to trade at $1,110.00 on Thursday.
These analysts made changes to their price targets on BlackRock following earnings announcement.
- Keefe, Bruyette & Woods analyst Alex Bond maintained the stock with an Outperform rating and raised the price target from $1,290 to $1,310.
- Wells Fargo analyst Daniel Welden maintained the stock with an Overweight rating and raised the price target from $1,230 to $1,250.
- Barclays analyst Benjamin Budish maintained the stock with an Overweight rating and cut the price target from $1,420 to $1,410.
- JP Morgan analyst Michael Cho maintained the stock with an Overweight rating and raised the price target from $1,435 to $1,449.
- Morgan Stanley analyst Mike Cyprys maintained the stock with an Overweight rating and raised the price target from $1,468 to $1,531.
Considering buying BLK stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Revenue increased 19% year over year (Y/Y) to $7.75 billion, topping the analyst consensus estimate of $7.52 billion. Adjusted earnings came in at $15.93 per share, ahead of the consensus estimate of $14.13.
Investment advisory, administration fees and securities lending revenue rose to $6.04 billion from $5.05 billion a year earlier. Securities lending revenue increased to $253 million from $203 million, led by higher spreads and increased average balances of securities on loan.
BlackRock shares rose 3.3% to trade at $1,110.00 on Thursday.
These analysts made changes to their price targets on BlackRock following earnings announcement.
- Keefe, Bruyette & Woods analyst Alex Bond maintained the stock with an Outperform rating and raised the price target from $1,290 to $1,310.
- Wells Fargo analyst Daniel Welden maintained the stock with an Overweight rating and raised the price target from $1,230 to $1,250.
- Barclays analyst Benjamin Budish maintained the stock with an Overweight rating and cut the price target from $1,420 to $1,410.
- JP Morgan analyst Michael Cho maintained the stock with an Overweight rating and raised the price target from $1,435 to $1,449.
- Morgan Stanley analyst Mike Cyprys maintained the stock with an Overweight rating and raised the price target from $1,468 to $1,531.
Considering buying BLK stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
78c2d17edf· 2026-10-16 01:38 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前